R. Scott Olson

Vorstandsvorsitzender bei Secretory IgA, Inc.

Health Technology

Consumer Services

Profil

R.
Scott Olson is the founder of Secretory IgA, Inc. Prior to that, he worked as a Principal at Unitech Pharmaceuticals, Inc. He holds an MBA from the University of Michigan.

Aktive Positionen von R. Scott Olson

Unternehmen	Position	Beginn
Secretory IgA, Inc. Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI.	Vorstandsvorsitzender	-

Alle aktiven Positionen von R. Scott Olson

Ehemalige bekannte Positionen von R. Scott Olson

Unternehmen	Position	Ende
Unitech Pharmaceuticals, Inc. Unitech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Unitech Pharmaceuticals, Inc. operates as a pharmaceutical research company. It engages in the discovery and development of novel treatments for a variety of autoimmune diseases and cancer. It operates as a pharmaceutical research company. The company was founded in 1994 by Jiajiu Shaw and is located in Ann Arbor, MI	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von R. Scott Olson im Detail an

Ausbildung von R. Scott Olson

University of Michigan

Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von R. Scott Olson im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Secretory IgA, Inc. Secretory IgA, Inc. Pharmaceuticals: MajorHealth Technology Secretory IgA, Inc. provides drug discovery and development services. It offers secretory immunoglobulin A, a biological therapeutic, which treats Clostridium difficile-associated disease. It develops orally available agents for the treatment of intestinal diseases mediated by bacterial toxins. The company founded by Michael R. Simon, Stephen C. Brown and Richard W. Frazee is headquartered in Ann Arbor, MI.	Health Technology
Unitech Pharmaceuticals, Inc. Unitech Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Unitech Pharmaceuticals, Inc. operates as a pharmaceutical research company. It engages in the discovery and development of novel treatments for a variety of autoimmune diseases and cancer. It operates as a pharmaceutical research company. The company was founded in 1994 by Jiajiu Shaw and is located in Ann Arbor, MI	Health Technology